Lido Advisors, LLC Astrazeneca PLC Transaction History
Lido Advisors, LLC
- $21.7 Billion
- Q4 2024
A detailed history of Lido Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lido Advisors, LLC holds 3,400 shares of AZN stock, worth $252,348. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,400
Previous 28,148
87.92%
Holding current value
$252,348
Previous $2.19 Million
89.88%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...